Sr.Mgr/AD - Market Access& Pricing Strategy - OBU

<p><span>Th</span><span>i</span>s<span> r</span><span>o</span><span>l</span>e <span>f</span><span>o</span>c<span>u</span>s<span>e</span>s <span>o</span>n <span>developing oncology new assets (new brands, new indications, BD assets, etc.) pricing and market access strategy and the related action plan &amp; program execution, based on the deep policy insights and brand knowledge, to achieve the best access outcomes for accelerating brand growth for the whole LCM, to accelerate patient access for benefitting from the new treatment</span>.</p><p><b><span>N</span><span>A</span><span>T</span><span>U</span><span>R</span><span>E<span> </span>&amp;<span> </span><span>S</span><span>CO</span>PE <span><span> </span></span></span></b><span>工</span><span> </span><span>作</span><span> </span><span>性</span><span> </span><span>质</span><span> </span><span>及</span><span> </span><span>范</span><span> </span><span>围</span></p><p><span>Lead to develop oncology brand-level Pricing &amp; Market Access strategy and action plan</span></p><ul><li><span>Understand brand knowledge, policy environment &amp; trend to analyze &amp; identify key access direction for new assets</span></li><li><span>Lead internal and external communication for developing the optimal pricing and market access strategy (pricing, reimbursement, VBP, tendering, distribution, insurance, etc.) and related action plan</span></li><li><span>Drive pricing &amp; market access proposal / recommendation for senior management decision</span></li></ul><p></p><p><span>​</span> <span>Lead to onco access cross-TA level project management and implementation to ensure the best outcomes</span></p><ul><li><span>Organize and manage the regular onco BU level access meeting to senior management update </span></li><li><span>Timely understand latest policy dynamics and identify the opportunity &amp; risk for onco access by brand level</span></li><li><span>Organize and drive team discussion &amp; actions to maximize the policy opportunity &amp; risk mitigation plan</span></li><li><span>Lead China onco access projects or support global onco access projects</span></li></ul><p></p><p><span>Job r<span>equ</span><span>i</span>r<span>e</span><span>m</span><span>en</span><span>t</span>s       </span><span>工</span> <span>作</span> <span>要</span> <span>求</span></p><p><b><span>A</span></b><b><span>ca</span></b><b><span>d</span></b><b><span>em</span></b><b><span>i</span></b><b>c / P<span>r</span><span>o</span>f<span>ess</span><span>i</span><span>on</span><span>a</span>l <span>Q</span><span>u</span><span>a</span><span>l</span><span>i</span>f<span>i</span><span>ca</span>t<span>io</span><span>n</span>:</b></p><p>B<span>a</span>c<span>he</span><span>l</span><span>o</span>r<span>’</span>s<span> deg</span>r<span>e</span>e <span>an</span>d <span>abo</span><span>v</span>e.  MBA degree is <span>p</span>r<span>e</span><span>f</span><span>e</span>r<span>ab</span><span>l</span>e, but not required.</p><p><b><span>T</span></b><b><span>e</span></b><b><span>c</span></b><b><span>h</span></b><b><span>n</span></b><b><span>i</span></b><b><span>ca</span></b><b>l / S<span>k</span><span>ill</span>s <span>T</span><span>ra</span><span>i</span><span>n</span><span>i</span><span>n</span>g:</b></p><ul><li><span>F</span><span>unda</span><span>m</span><span>en</span><span>t</span><span>a</span>l k<span>no</span><span>w</span><span>l</span><span>edg</span>e <span>an</span>d <span>unde</span>r<span>s</span><span>t</span><span>and</span><span>i</span><span>n</span>g <span>o</span>f <span>t</span><span>h</span>e <span>Chin</span>a onco <span>pha</span>r<span>m</span><span>a</span>c<span>eu</span><span>t</span><span>i</span>c<span>a</span>l <span>l</span><span>and</span><span>s</span>c<span>ap</span>e <span>and </span><span>m</span><span>a</span>rk<span>e</span>t <span>a</span>cc<span>e</span><span>s</span>s <span>environment, deep understanding on China onco access dynamics</span> S<span>t</span>r<span>on</span>g cr<span>o</span><span>ss</span>-<span>f</span><span>un</span>c<span>t</span><span>i</span><span>on</span><span>a</span>l <span>p</span>r<span>o</span><span>j</span><span>e</span>ct m<span>anage</span><span>m</span><span>en</span>t <span>s</span>k<span>i</span><span>ll</span>s.</li><li>Pr<span>o</span><span>v</span><span>e</span>n <span>s</span><span>u</span>cc<span>e</span><span>s</span>s <span>i</span>n <span>l</span><span>ead</span><span>i</span><span>n</span>g cr<span>o</span><span>ss</span>-<span>f</span><span>un</span>c<span>t</span><span>i</span><span>on</span><span>a</span>l<span> t</span><span>ea</span>m <span>a</span>c<span>t</span><span>i</span><span>v</span><span>i</span><span>t</span><span>ie</span>s. M<span>anag</span>e <span>an</span>d <span>i</span><span>n</span><span>f</span><span>l</span><span>uen</span>ce <span>m</span><span>ul</span><span>t</span><span>i</span><span>p</span><span>l</span>e <span>i</span><span>n</span><span>t</span><span>e</span>r<span>n</span><span>a</span>l <span>an</span>d <span>e</span><span>x</span><span>t</span><span>e</span>r<span>n</span><span>a</span>l <span>s</span><span>t</span><span>a</span>k<span>eho</span><span>l</span><span>de</span>rs</li><li><span>Strong business acumen, Strategic thinking and analytic</span><span>a</span>l <span>s</span>k<span>i</span><span>l</span><span>l</span>s</li><li><span> Quick learner with passion to work in a fast-paced environment</span></li><li>Exc<span>el</span><span>l</span><span>en</span>t c<span>o</span>m<span>m</span><span>uni</span>c<span>a</span><span>t</span><span>i</span><span>o</span>n<span> &amp; presentation </span><span>s</span>k<span>i</span><span>l</span><span>l</span>s (E<span>n</span><span>g</span><span>li</span><span>s</span>h <span>an</span>d <span>Ch</span><span>i</span><span>ne</span><span>s</span><span>e</span>, <span>bo</span><span>t</span>h <span>o</span>r<span>a</span>l <span>an</span>d <span>w</span>r<span>i</span><span>tt</span><span>en</span>)</li></ul><p><b>P<span>rev</span><span>iou</span>s <span>W</span><span>o</span><span>r</span>k E<span>x</span><span>p</span><span>er</span><span>i</span><span>e</span><span>n</span><span>ce</span>:  </b></p><p><b>A</b>t <span>l</span><span>ea</span><span>s</span>t 5<b> <span>year</span>s <span>wo</span><span>r</span>k <span>e</span><span>x</span><span>p</span><span>er</span><span>i</span><span>e</span><span>n</span><span>c</span>e </b><span>i</span>n M<span>N</span><span>C</span><span>s</span>,<span> oncology marketing/NPP or market access, or </span><span>t</span><span>o</span>p <span>t</span><span>i</span><span>e</span>r c<span>on</span><span>s</span><span>u</span><span>l</span><span>t</span><span>i</span><span>n</span>g <span>fi</span><span>r</span>m.</p><p><b><span>Des</span></b><b><span>i</span></b><b><span>ra</span></b><b><span>bl</span></b><b>e <span>q</span><span>u</span><span>a</span><span>l</span><span>i</span>t<span>i</span><span>e</span>s</b></p><p>P<span>ha</span>r<span>m</span><span>a</span>c<span>eu</span><span>t</span><span>i</span>c<span>a</span>l M<span>N</span>C <span>w</span><span>o</span>rk <span>e</span><span>x</span><span>pe</span><span>r</span><span>i</span><span>en</span>ce or Consulting working experience for pharmaceutical industry K<span>no</span><span>w</span><span>l</span><span>edg</span>e / <span>e</span><span>x</span><span>pe</span><span>r</span><span>i</span><span>en</span>c<span>e</span>: <span>P</span>r<span>o</span><span>j</span><span>e</span><span>c</span>t <span>m</span><span>anag</span><span>e</span><span>m</span><span>en</span>t &amp; access experience</p><p><b><span>L</span></b><b><span>a</span></b><b><span>n</span></b><b><span>g</span></b><b><span>u</span></b><b><span>a</span></b><b><span>g</span></b><b>e <span>a</span><span>b</span><span>i</span><span>li</span>ty</b></p><p><span>F</span><span>l</span><span>uen</span>cy <span>i</span>n <span>bo</span><span>t</span>h E<span>n</span><span>g</span><span>li</span><span>s</span>h <span>an</span>d <span>Ch</span><span>i</span><span>ne</span><span>s</span>e (<span>bo</span><span>t</span>h <span>o</span>r<span>a</span>l <span>an</span>d <span>w</span>r<span>i</span><span>t</span><span>t</span><span>en</span>)</p><p><b><span>C</span></b><b><span>o</span></b><b><span>m</span></b><b><span>p</span></b><b><span>u</span></b><b>t<span>e</span>r <span>l</span><span>i</span>t<span>erac</span>y</b></p><p><b>1. </b>Pr<span>o</span><span>f</span><span>i</span>c<span>i</span><span>en</span>cy <span>i</span>n <span>M</span><span>i</span>cr<span>o</span><span>s</span><span>o</span><span>f</span>t <span>O</span><span>ff</span><span>i</span>ce <span>s</span><span>u</span><span>i</span><span>t</span>e <span>o</span>f <span>p</span>r<span>odu</span>c<span>t</span>s</p><p><b>2. </b>Exc<span>el</span><span>l</span><span>en</span>t PPT/presentation <span>s</span>k<span>i</span><span>ll</span>s</p><p style="text-align:inherit"></p><p style="text-align:left"><b>Date Posted</b></p>28-Jan-2026<p style="text-align:inherit"></p><p style="text-align:left"><b>Closing Date</b></p>30-Mar-2026<p></p><p></p><p>AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.</p>